FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide. Indeed, despite the benefit of sorafenib in the treatment of some patients with HCC, the majority of these patients have a poor response to or intolerance of sorafenib, resulting in further tumor progres...
Saved in:
Main Authors: | Yingru Zhi (Author), Mubalake Abudoureyimu (Author), Hao Zhou (Author), Ting Wang (Author), Bing Feng (Author), Rui Wang (Author), Xiaoyuan Chu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma
by: Kai Zhang, et al.
Published: (2018) -
LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling
by: Jiang Shao, et al.
Published: (2020) -
circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324
by: Hanqin Weng, et al.
Published: (2021) -
Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer
by: Zhaowei Sun, et al.
Published: (2021) -
Deciphering the molecular mechanism of tetrandrine in inhibiting hepatocellular carcinoma and increasing sorafenib sensitivity by combining network pharmacology and experimental evaluation
by: Biao Niu, et al.
Published: (2022)